Mechanisms of disease: Pre-eclampsia

被引:250
作者
Noris, M
Perico, N
Remuzzi, G
机构
[1] Mario Negri Inst Pharmacol Res, Transplant Res Ctr Chiara Cucchi De Alessandri, Lab Immunol & Genet Transplantat & Rare Dis, I-24020 Bergamo, Italy
[2] Mario Negri Inst Pharmacol Res, Lab Adv Dev Drugs, Clin Res Ctr Rare Dis, I-24020 Bergamo, Italy
来源
NATURE CLINICAL PRACTICE NEPHROLOGY | 2005年 / 1卷 / 02期
关键词
nitric oxide; oxygen radicals; pathophysiology; pre-eclampsia; vascular endothelial growth factor;
D O I
10.1038/ncpneph0035
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Pre-eclampsia, a syndrome of pregnant women, is one of the leading causes of maternal and fetal morbidity and mortality. Despite active research, the etiology of this disorder remains an enigma. Recent work has, however, provided promising explanations for the causation of the disorder and some of its phenotypes. Evidence indicates that the symptoms of hypertension and proteinuria, upon which the diagnosis of pre-eclampsia is based, have several underlying causes. Nevertheless, the treatment of pre-eclampsia has not changed significantly in over 50 years. This review describes the most recent insights into the pathophysiology of pre-eclampsia from both basic and clinical research, and attempts to provide a unifying hypothesis to reconcile the abnormalities at the feto-placental level and the clinical features of the maternal syndrome. The novel findings outlined in this review provide a rationale for potential future prophylactic and therapeutic interventions for pre-eclampsia.
引用
收藏
页码:98 / 114
页数:17
相关论文
共 142 条
[61]   Should the definition of preeclampsia include a rise in diastolic blood pressure of ≥15 mm Hg to a level <90 mm Hg in association with proteinuria? [J].
Levine, RJ ;
Ewell, MG ;
Hauth, JC ;
Curet, LB ;
Catalano, PM ;
Morris, CD ;
Choudhary, G ;
Sibai, BM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (04) :787-792
[62]  
Li DK, 2000, AM J EPIDEMIOL, V151, P57, DOI 10.1093/oxfordjournals.aje.a010122
[63]   Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta [J].
Li, H ;
Gu, B ;
Zhang, Y ;
Lewis, DF ;
Wang, Y .
PLACENTA, 2005, 26 (2-3) :210-217
[64]   Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells [J].
Li, H ;
Meininger, CJ ;
Hawker, JR ;
Haynes, TE ;
Kepka-Lenhart, D ;
Mistry, SK ;
Morris, SM ;
Wu, GY .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (01) :E75-E82
[65]   Unraveling the mysteries of preeclampsia [J].
Lindheimer, MD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (01) :3-4
[66]   Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia [J].
Livingston, JC ;
Chin, R ;
Haddad, B ;
Mckinney, ET ;
Ahokas, R ;
Sibai, BM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (06) :1554-1557
[67]   Preeclampsia:: from epidemiological observations to molecular mechanisms [J].
López-Jaramillo, P ;
Casas, JP ;
Serrano, N .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2001, 34 (10) :1227-1235
[68]   Cyclic guanosine 3',5' monophosphate concentrations in pre-eclampsia: Effects of hydralazine [J].
LopezJaramillo, P ;
Narvaez, M ;
Calle, A ;
Rivera, J ;
Jacome, P ;
Ruano, C ;
Nava, E .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 (01) :33-38
[69]   Nitric oxide dysfunction in the pathophysiology of preeclampsia [J].
Lowe, DT .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2000, 4 (04) :441-458
[70]   Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? [J].
Luttun, A ;
Carmeliet, P .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :600-602